Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (21-30 of 449) with videos related to

Pageof 45
Sort By:
Korean Journal of Radiology|February 27, 2025
A Radiologist's Guide to IDH-Wildtype Glioblastoma for Efficient Communication With Clinicians: Part II-Essential Information on Post-Treatment ImagingPhilipp Vollmuth, Philipp Karschnia, Felix Sahm, et al.
Cancer Epidemiology|July 21, 2019
Incidence, mortality and outcome of meningiomas: A population-based study from GermanyBernd Holleczek, Daniel Zampella, Steffi Urbschat, et al.
Archives of Neurology|December 14, 2011
Addressing diffuse glioma as a systemic brain disease with single-cell analysisFelix Sahm, David Capper, Astrid Jeibmann, et al.
Cancers|December 11, 2022
DNA-Methylation Analysis as a Tool for Thymoma ClassificationTimo Gaiser, Daniela Hirsch, Isabel Porth, et al.
Cancers|April 3, 2021
The Prognostic Value of Methylation Signatures and <i>NF2</i> Mutations in Atypical MeningiomasRahmina Meta, Henning B Boldt, Bjarne W Kristensen, et al.
Neuro-Oncology|May 9, 2017
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrenceÜmmügülsüm Yesilöz, Elmar Kirches, Christian Hartmann, et al.
Neuropathology and Applied Neurobiology|May 13, 2025
Testing Meningiomas With Methylation Arrays: Insights and Recommendations From a Large Single-Centre StudyFernanda Ruiz, Rossella Rispoli, Zane Jaunmuktane, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 2021
Primary CNS lymphoma after CLIPPERS: a case seriesSofia Doubrovinskaia, Felix Sahm, Marc Christian Thier, et al.
Orphanet Journal of Rare Diseases|July 3, 2025
Targeted treatment of hypophosphatemia with trametinib in HRAS-related mosaic RASopathyAdil Mirza, Corinne Rossi, Andreas Kulozik, et al.
Neuro-Oncology Advances|May 16, 2022
Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphomaLeon D Kaulen, Christoph Gumbinger, Felix Hinz, et al.
Pageof 45

Showing results (21-30 of 449) with videos related to

Sort By:
Pageof 45
Korean Journal of Radiology|February 27, 2025
A Radiologist's Guide to IDH-Wildtype Glioblastoma for Efficient Communication With Clinicians: Part II-Essential Information on Post-Treatment ImagingPhilipp Vollmuth, Philipp Karschnia, Felix Sahm, et al.
Cancer Epidemiology|July 21, 2019
Incidence, mortality and outcome of meningiomas: A population-based study from GermanyBernd Holleczek, Daniel Zampella, Steffi Urbschat, et al.
Archives of Neurology|December 14, 2011
Addressing diffuse glioma as a systemic brain disease with single-cell analysisFelix Sahm, David Capper, Astrid Jeibmann, et al.
Cancers|December 11, 2022
DNA-Methylation Analysis as a Tool for Thymoma ClassificationTimo Gaiser, Daniela Hirsch, Isabel Porth, et al.
Cancers|April 3, 2021
The Prognostic Value of Methylation Signatures and <i>NF2</i> Mutations in Atypical MeningiomasRahmina Meta, Henning B Boldt, Bjarne W Kristensen, et al.
Neuro-Oncology|May 9, 2017
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrenceÜmmügülsüm Yesilöz, Elmar Kirches, Christian Hartmann, et al.
Neuropathology and Applied Neurobiology|May 13, 2025
Testing Meningiomas With Methylation Arrays: Insights and Recommendations From a Large Single-Centre StudyFernanda Ruiz, Rossella Rispoli, Zane Jaunmuktane, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 2021
Primary CNS lymphoma after CLIPPERS: a case seriesSofia Doubrovinskaia, Felix Sahm, Marc Christian Thier, et al.
Orphanet Journal of Rare Diseases|July 3, 2025
Targeted treatment of hypophosphatemia with trametinib in HRAS-related mosaic RASopathyAdil Mirza, Corinne Rossi, Andreas Kulozik, et al.
Neuro-Oncology Advances|May 16, 2022
Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphomaLeon D Kaulen, Christoph Gumbinger, Felix Hinz, et al.
Pageof 45